Breztri aerosphere inhaler 10.7GM
Ended Awarded Last action
- Contract number
- SPE2DR26F7VL3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,204
Award facts
- Contract value 100% obligated
- $18,203.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,203.68 on January 28, 2026, for BREZTRI Aerosphere Inhaler 10.7GM to support federal medical procurement needs. This non-set-aside contract employs firm fixed-price pricing and is scheduled for completion by January 29, 2026. The award was issued by the Defense Logistics Agency (DLA), which procures medical supplies and pharmaceuticals for the Department of Defense and military healthcare systems. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical commodities to military treatment facilities and veterans' healthcare programs worldwide.
BREZTRI Aerosphere is a combination maintenance inhalation therapy used in treating chronic obstructive pulmonary disease, representing the type of specialty pharmaceutical products AmerisourceBergen routinely delivers through its federal contracts. The company's extensive federal contracting portfolio demonstrates consistent capability to fulfill government procurement requirements through open competition, delivering diverse pharmaceutical products across multiple therapeutic domains including respiratory, neurological, pain management, and other specialized medical treatments to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F7VL3?
SPE2DR26F7VL3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VL3 worth?
The government has obligated $18,204 on SPE2DR26F7VL3.
Is contract SPE2DR26F7VL3 an order under another contract?
Yes. SPE2DR26F7VL3 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VL3 competed?
The extent of competition for SPE2DR26F7VL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award